https://www.selleckchem.com/products/Y-27632.html
76; 95% CI, 2.545-22.975). The SIR values were 2.08 (95% CI, 0.419-3.741) and 10.81 (95% CI, 0.216-21.404) for breast cancer and NHL, respectively. The risk of hematological and solid cancers was higher in the patients with pSS when compared to general population. In our pSS cohort, the risk for ovarian cancer was found to be increased, which has not been previously reported in the literature. The risk of hematological and solid cancers was higher in the patients with pSS when compared to general population. In our pSS cohort, the risk
Like
Comment
Share
